polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride for oral solution
Drug data last refreshed 1h ago · AI intelligence enriched 1h ago
SUFLAVE is an oral bowel preparation solution containing polyethylene glycol 3350, sodium sulfate, potassium chloride, magnesium sulfate, and sodium chloride. It is used to cleanse the colon prior to colonoscopy or other gastrointestinal procedures. The solution works osmotically to draw fluid into the bowel and promote evacuation.
Early-stage market adoption following recent approval suggests growing field sales and specialty pharmacy engagement opportunities within a maturing category.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
SUFLAVE offers entry-level to mid-career opportunities in a commercial-focused, non-specialty environment targeting gastroenterology and ambulatory surgery centers. Career growth depends on rapid market share capture and account management excellence rather than clinical innovation or therapy expansion.
Worked on SUFLAVE at R-Pharm US? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/moUpgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/mo